Brief: Revive Therapeutics announces term sheet with InMed Pharmaceuticals
22/02/2017 12:02
Feb 22 (Reuters) - Revive Therapeutics Ltd RVV.V -
* Company has entered into a term sheet agreement with InMed
Pharmaceuticals Inc
* Agreement with InMed Pharma for discovery and development
of cannabinoid-based therapies targeting kidney diseases
Source text for Eikon: ID:nCCN8Xb2hT
Further company coverage: RVV.V
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure